Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine

Redox Report

Volumn 15, Issue 6, 2010, Pages 259-267

  Couto, Diana ^a   Ribeiro, Daniela ^a   Freitas, Marisa ^a   Gomes, Ana ^a   Lima, José L F C ^a   Fernandes, Eduarda ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

5 aminosalicylic acid; reactive nitrogen species; reactive oxygen species; scavenging activity; sulfapyridine; sulfasalazine

Indexed keywords

BICARBONATE; CARBONIC ACID; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; MESALAZINE; NITRIC OXIDE; PEROXY RADICAL; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE; SINGLET OXYGEN; SULFAPYRIDINE; SUPEROXIDE;

ARTICLE; CONTROLLED STUDY; PRIORITY JOURNAL; SCAVENGING SYSTEM; SCREENING TEST;

AMINOSALICYLIC ACID; HYDROGEN PEROXIDE; MOLECULAR STRUCTURE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SULFAPYRIDINE; SULFASALAZINE; SUPEROXIDES;

EID: 78651112199     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/135100010X12826446921707     Document Type: Article

References (46)

1. Nielsen OH, Munck LK. Drug insight: Aminosalicylates for the treatment of IBD. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 160-170.
2. Nikfar S, Rahimi R, Rezaie A, Abdollahi M. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Dig Dis Sci 2009; 54: 1157-1170.
3. Plosker GL, Croom KF. Sulfasalazine: A review of its use in the management of rheumatoid arthritis. Drugs 2005; 65: 1825-1849.
4. Donahue KE, Gartlehner G, Jonas DE et al. Systematic review: Comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med 2008; 148: 124-134.
5. Reed MR, Taylor AL. Tumour necrosis factor inhibitors in ankylosing spondylitis. Intern Med J 2009; 38: 781-789.
6. Stenson WF, Lobos E. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest 1982; 69: 49-47.
7. Hawkey CJ, Truelove SC. Inhibition of prostaglandin synthetase in human rectal mucosa. Gut 1983; 24: 213-217.
8. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986; 91: 837-844.
9. Barrera P, Boerbooms AM, van der Putte LB, van der Meer JW. Effects of antirheumatic agents on cytokines. Semin Arthritis Rheum 1996; 25: 234-253.
10. Hirohata S, Ohshima N, Yanagida T, Aramaki K. Regulation of human B cell function by sulfasalazine and its metabolites. Int Immunopharmacol 2001; 2: 631-640.
11. Shanahan F, Niederlehner A, Carramanzana N, Anton P. Sulfasalazine inhibits the binding of TNF alpha to its receptor. Immunopharmacology 1990; 20: 217-224.
12. Egan LJ, Mays DC, Huntoon CJ et al. Inhibition of interleukin-1- stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem 1999; 274: 26448-26453.
13. Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K. Mesalazine inhibits activation of transcription factor NF-êB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol 2000; 95: 3452-3457.
14. Burress GC, Musch MW, Jurivich DA, Welk J, Chang EB. Effects of mesalamine on the hsp72 stress response in rat IEC-18 intestinal epithelial cells. Gastroenterology 1997; 113: 1474-1479.
15. Ahnfelt-Ronne I, Nielson OH, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1990; 98: 1162-1169.
16. Desreumaux P, Ghosh S. Review article: Mode of action and delivery of 5-aminosalicylic acid-new evidence. Aliment Pharmacol Ther 2006; 241: S2-S9.
17. Dallegri F, Ottonello L, Ballestrero A, Bogliolo F, Ferrando F, Patrone F. Cytoprotection against neutrophil derived hypochlorous acid: A potential mechanism for the therapeutic action of 5- aminosalicylic acid in ulcerative colitis. Gut 1990; 31: 184-186.
18. Prakash A, Markham A. Oral delayed-release mesalazine: A review of its use in ulcerative colitis and Crohn's disease. Drugs 1999; 57: 383-408.
19. Sandoval M, Liu X, Mannick EE, Clark DA, Miller MJ. Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. Gastroenterology 1997; 113: 1480-1488.
20. Craven PA, Pfansteil J, Saito R, DeRubertis FR. Actions of sulfasalazine and 5-aminosalicylic acid reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity. Gastroenterology 1987; 92: 1998-2008.
21. Kvietys PR, Morgan-Smith S, Grisham MB, Manci EA. 5- Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat. Gastroenterology 1988; 94: 733-738.
22. Del Soldato P, Campieri M, Brignola C et al. A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: Interaction with oxygen free radicals. Gastroenterology 1985; 189: 1215-1216.
23. Ahnfelt-Ronne I, Nielson OH. The anti-inflammatory moiety of sulfasalasine, 5-aminosalacilic acid, is radical scavenger. Agents Actions 1987; 21: 191-194.
24. Ahnfelt-Ronne I, Nielson OH, Bukhave K, Elmgreen J. Sulfasalazine and its anti-inflammatory metabolite 5-aminosalicylic acid: Effect arachidonic acid metabolism in human neutrophils, and free radical scavenging. Adv Prostaglandin Thromboxane Leukotriene Res 1987; 17B: 918-922.
25. Aruoma OI, Wasil M, Halliwell B, Hoey MB, Butler J. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol 1987; 36: 3739-3742.
26. Kanerud L, Hafstrom I, Ringertz B. Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: Role of cytosolic free calcium. Ann Rheum Dis 1990; 49: 296-300.
27. Neal TM, Winterbourn CC, Vissers MCM. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Biochem Pharmacol 1987; 36: 2765-2768.
28. Joshi R, Kumar S, Unnikrishnan M, Mukherjee T. Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: Mechanistic aspects and antioxidant activity. Free Radic Res 2005; 39: 1163-1172.
29. Fernandes E, Toste SA, Lima JLFC, Reis S. The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species. Free Radic Biol Med 2003; 35: 1008-1017.
30. Fernandes E, Costa D, Toste SA, Lima JLFC, Reis S. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med 2004; 37: 1895-1905.
31. Costa D, Gomes A, Reis S, Lima JLFC, Fernandes E. Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. Life Sci 2005; 76 :2841-2848.
32. Costa D, Vieira A, Fernandes E. Dipyrone and aminopyrine are effective scavengers of reactive nitrogen species. Redox Rep 2006; 11:136-142.
33. Costa D, Moutinho L, Lima JLFC, Fernandes E. Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non-steroidal anti-inflammatory drugs. Biol Pharm Bull 2006; 29: 1659-1670.
34. Costa D, Gomes A, Lima JLFC, Fernandes E. Singlet oxygen scavenging activity by non-steroidal anti-inflammatory drugs. Redox Rep 2008; 13: 153-160.
35. Gomes A, Fernandes E, Silva AM et al. 2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species. Bioorg Med Chem 2007; 15: 6027-6036.
36. Whiteman M, Ketsawatsakul U, Halliwell B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann NY Acad Sci 2002; 962: 242-259.
37. Kettle AJ, Winterbourn CC. Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs. Biochem Pharmacol 1991; 41: 1485-1492.
38. Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr Opin Hematol 2000; 7: 53-58.
39. Liu ZC, McClelland RA, Uetrecht JP. Oxidation of 5-aminosalicylic acid by hypochlorous acid to a reactive iminoquinone. Possible role in the treatment of inflammatory bowel diseases. Drug Metab Dispos 1995; 23: 246-250.
40. Steinbeck MJ, Khan AU, Karnovsky MJ. Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. J Biol Chem 1992; 267: 13425-13433.
41. Molin L, Stendahl O. The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis. Acta Med Scand 1979; 206: 451-457.
42. Stenson WF, Mehta J, Spilberg I. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (fMLP) to its receptor on human neutrophils. Biochem Pharmacol 1984; 33: 407-412.
43. Miyachi Y, Yoshioka A, Imamura S, Niwa Y. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut 1987; 28: 190-195.
44. Radi R, Cosgrove TP, Beckman JS, Freeman BA. Peroxynitriteinduced luminol chemiluminescence. Biochem J 1993; 290: 51-57.
45. Denicola A, Freeman BA, Trujillo M, Radi R. Peroxynitrite reaction with carbon dioxide/bicarbonate: Kinetics and influence on peroxynitrite-mediated oxidations. Arch Biochem Biophys 1996; 333: 49-58.
46. Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 1998; 25: 392-403.